Encompass Health Corporation (EHC) stock analysis
Healthcare · Medical Care Facilities
From the 10-K filed 2026-02-26
Business type: Capital compounder
How it makes money
Encompass Health earns revenue by treating patients recovering from major illnesses in inpatient rehabilitation hospitals, driven primarily by patient discharge volume and pricing.
Patients and payors pay Encompass Health for specialized inpatient rehabilitative care delivered following physician referrals. Substantially all, or 92%, of patients are admitted from acute-care hospitals for conditions such as strokes and hip fractures that require intensive therapy.
Profitability is primarily driven by patient discharge volumes, pricing adjustments, and managing lengths of stay efficiently. For 2025, total net operating revenues reached $5,935.2 million, up from $5,373.2 million in 2024, driven by growth in both patient discharges and pricing.
What protects it: the moat
Encompass Health protects its market position through scale as the nation's largest owner and operator of inpatient rehabilitation hospitals.
The company operates 173 inpatient rehabilitation hospitals across 39 states and Puerto Rico as of December 31, 2025, supported by geographic concentrations in states like Florida and Texas.
Management asserts that its clinical outcomes, specialized stroke certifications across 148 hospitals, and established relationships with healthcare systems create a strong competitive moat against alternative sites of care.
What growth costs
Encompass Health reinvests capital to expand hospital bed capacity, open de novo facilities, and fund organic growth opportunities.
The company pursues growth by developing new inpatient rehabilitation hospitals and adding bed capacity to existing locations, such as adding 177 new beds to existing hospitals in 2025.
Capital is also deployed toward joint venture partnerships with healthcare providers, common stock repurchases, and quarterly cash dividends paid to shareholders.
What could damage it
Reductions in government reimbursement rates could directly impair net operating revenues and overall financial results.
Because Encompass Health derives a substantial portion of its net operating revenues from the Medicare program, any legislative or regulatory changes reducing reimbursement levels would directly pressure earnings.
Automatic federal spending reductions, such as Medicare sequestration or productivity adjustments mandated by the ACA, constrain payment growth and could outpace the rising operational costs incurred by the hospitals.
About Encompass Health Corporation
Encompass Health Corporation operates inpatient rehabilitation hospitals in the United States and Puerto Rico. The company offers specialized rehabilitative treatment, using technology and therapy, on an inpatient basis for patients recovering from a major injury or illness and seeking to regain functional ability, independence, and quality of life; medical, nursing, therapy, and ancillary services; and rehabilitative care to patients who are recovering from conditions, such as stroke and other neurological disorders, cardiac and pulmonary conditions, brain and spinal cord injuries, complex orthopedic conditions, and amputations. It offers services through the Medicare program to the federal government, managed care plans and private insurers, state governments, and other patients. The company was formerly known as HealthSouth Corporation and changed its name to Encompass Health Corporation in January 2018. Encompass Health Corporation was incorporated in 1984 and is based in Birmingham, Alabama.